Article
Gene signature predictive of hepatocellular carcinoma patient response to transarterial chemoembolization.
International journal of biological sciences - 1 Jan 2019
Fako Valerie, Martin Sean P, Pomyen Yotsawat, Budhu Anuradha, Chaisaingmongkol Jittiporn, Franck Sophia, Lee Joyce Man-Fong, Ng Irene Oi-Lin, Cheung Tan-To, Wei Xiyang, Liu Niya, Ji Junfang, Zhao Lei, Liu Zhaogang, Jia Hu-Liang, Tang Zhao-You, Qin Lun-Xiu, Kloeckner Roman, Marquardt Jens, Greten Tim, Wang Xin Wei
Abstract excerpt
Transarterial chemoembolization (TACE) is a commonly used treatment modality in hepatocellular carcinoma (HCC). The ability to identify patients who will respond to TACE represents an important clinical need, and tumor gene expression patterns may be associated with TACE response. We investigated whether tumor transcriptome is associated with TACE response in patients with HCC. We analyzed transcriptome data of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.